A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings
Completed
- Conditions
- Menorrhagia
- Registration Number
- NCT01643304
- Lead Sponsor
- Bayer
- Brief Summary
This field based, questionnaire study will document observational data on womens perception of menstrual bleeding in a cross-section of women in Sweden. Each subject will complete the questionnaire at one occasion.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1547
Inclusion Criteria
- All women 40-45 years available in the web-panel of SIFO
- Completion of the web-based questionnaire
Exclusion Criteria
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of subjectively experienced heavy menstrual bleeding assessed by questionnaire Once at baseline
- Secondary Outcome Measures
Name Time Method Social consequences of heavy menstrual bleedings assessed by questionnaire Once at baseline Costs; e.g. pads, absence from work, loss of income assessed by questionnaire Once at baseline The treatments given for heavy menstrual bleedings, as surgery or medication assessed by questionnaire Once at baseline
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie menstrual bleeding perception in NCT01643304?
How does the Swedish study compare to standard-of-care for menorrhagia management?
Are there specific biomarkers identified for predicting response to non-pharmacological interventions in menorrhagia?
What adverse events are associated with behavioral interventions for menstrual disorders in observational studies?
What non-drug strategies are being explored by Bayer for menorrhagia treatment in cross-sectional trials?